Norway
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.74 M
|
Dec. 31, 2023 | USD 5.15 | 1.58% |
|
Norway |
|
2 |
USD 1.52 M
|
Dec. 31, 2023 | USD 4.11 | 5.18% |
|
Norway |
|
3 |
USD -18.64 M
|
Dec. 31, 2023 | USD 0.19 | 1.62% |
|
Norway |
|
4 |
USD -22.10 M
|
Dec. 31, 2023 | USD 0.71 | -1.42% |
|
Norway |
|
5 |
USD -96.62 M
|
Dec. 31, 2023 | USD 0.23 | 0.18% |
|
Norway |
The Vaccines company in Norway with the highest Operating Cash Flow is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD 4.74 M.
The Vaccines company in Norway with the lowest Operating Cash Flow is Nykode Therapeutics AS (Oslo Stock Exchange: NYKD.OL) at USD -96.62 M.
The top 10 Vaccines companies in Norway by Operating Cash Flow are Photocure ASA, Gentian Diagnostics ASA, Ultimovacs ASA, BerGenBio ASA and Nykode Therapeutics AS.
The bottom 10 Vaccines companies in Norway by Operating Cash Flow are Nykode Therapeutics AS, BerGenBio ASA, Ultimovacs ASA, Gentian Diagnostics ASA and Photocure ASA.